Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Emsella for Reducing tSUI After HOLEP

NCT: NCT07580404 · NOT_YET_RECRUITING

NCT IDNCT07580404
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2028-06

Brief Summary

This study aims to investigate the effectiveness of the Emsella chair treatments at different timepoints. Before and after the holmium laser enucleation of the prostate (HoLEP).

Frequently Asked Questions

What is Emsella for Reducing tSUI After HOLEP?

Emsella for Reducing tSUI After HOLEP is a clinical trial registered under NCT07580404. Current status: NOT_YET_RECRUITING.

What is the status of NCT07580404?

The current status of NCT07580404 (Emsella for Reducing tSUI After HOLEP) is: NOT_YET_RECRUITING.

When did Emsella for Reducing tSUI After HOLEP start?

Emsella for Reducing tSUI After HOLEP started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑